Skip to content

SPROTTE® 211163-29ARecalls & reported problems

Pajunk GmbH Medizintechnologie · Needle · Class 2

Adverse event reports
3
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 04048223116470), received between Feb 14, 2025 and Jul 18, 2025 — classified as 1 injury, 2 malfunctions.

The most frequently reported specific device problem is “Break” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 2 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 1 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Break1
  • Device Stenosis1
  • Difficult or Delayed Separation1
  • Nonstandard Device1
  • Obstruction of Flow1

Patient problems

  • No Clinical Signs, Symptoms or Conditions3

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 18, 2025Break; Break

    IRN# (B)(4) INCIDENT OCCURRED IN UK: PANJUNK SPROTTE 25X90MM NEEDLE BROKE WHILE PULLING OUT, HOWEVER ENTIRE NEEDLE COULD BE RETRIEVED.CONFIRMED BY -NOTING BEVEL AT DISTAL END, COMPARING LENGTH OF BROKEN PARTS WITH ANOTHER NEEDLE (90MM). REPORTER NOTES - "IDON'T THINK THERE WAS NOT ANY EXCESSIVE FORCE INVOLVED. JUST A ROUTINE SPINAL WITH MILD DIFFICULTY DUE TO HIGH BMI. THE NEEDLE BREAK IN SUCH CASE RAISES CONCERN. I DON'T THINK THINGS COULD HAVE BEEN DONE DIFFERENTLY FROM POINT OF VIEW OF TECHNIQUE, HUMAN FACTORS ETC" BMI 40+.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22539491 ↗
  • MalfunctionFeb 14, 2025Obstruction of Flow; Obstruction of Flow

    IRN# (B)(4) INCIDENT OCCURRED IN GREAT BRITAIN: NEEDLE WAS USED ON A PATIENT BY AN ANAESTHETIST BUT WAS UNABLE TO INJECT DOWN THE NEEDLE. THE NEEDLE WAS REPOSITIONED THREE TIMES BUT HAD NO FLOW OF CSF WITH EACH ATTEMPT. THE NEEDLE WAS ASSUMED TO BE BLOCKED AND A NEW NEEDLE WAS USED FROM THE SAME BATCH. THE NEW NEEDLE HAD NO ISSUES.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21382816 ↗
  • MalfunctionFeb 14, 2025Nonstandard Device; Difficult or Delayed Separation; Device Stenosis; Nonstandard Device; Difficult or Delayed Separation; Device Stenosis

    (B)(4). INCIDENT OCCURRED IN GREAT BRITAIN: SPINAL NEEDLE BEING USED IN DELIVERY SUITE FOR LABOURING PATIENT. ON WITHDRAWING THE INTRODUCER IT GOT STUCK IN THE NEEDLE SO THE ENTIRE NEEDLE AND INTRODUCER REMOVED AND A FRESH ONE USED. A NEW NEEDLE USED - PATIENT UNNECESSARILY HAD TWO SPINAL NEEDLE PASSES. ON EXAMINING THE FAULTY NEEDLE, THERE APPEARS TO BE EXCESS FRICTION BETWEEN THE SPINAL NEEDLE AND THE INTRODUCER IMPLYING THAT THE SPINAL NEEDLE HAS A NARROWING. THE INTRODUCED COULD BE REMOVED (OUTSIDE OF THE PATIENT) BUT THEN THE SPINAL NEEDLE COULD NOT BE FLUSHED WITH SALINE EASILY.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21382653 ↗

Other NEEDLE, CONDUCTION, ANESTHETIC (W/WO INTRODUCER) devices

All NEEDLE, CONDUCTION, ANESTHETIC (W/WO INTRODUCER) devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.